Fortress Biotech Inc

NASDAQ:FBIO   3:59:47 PM EDT
2.75
-0.02 (-0.72%)
Other Pre-Announcement

Fortress Biotech Posts Q3 Non-GAAP Loss Per Share $0.07

Published: 11/09/2020 22:43 GMT
Fortress Biotech Inc (FBIO) - Fortress Biotech Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights.
Q3 GAAP Loss per Share $0.20.
Q3 Earnings per Share Estimate $-0.22 -- Refinitiv Ibes Data (analyst estimates).
Q3 Non-GAAP Loss per Share $0.07.
Qtrly Net Revenue $9.5 Million Versus $9.8 Million.
Q3 Revenue View $11.3 Million -- Refinitiv Ibes Data (analyst estimates).
Rolling Submission of New Drug Application for Cutx-101 is Expected to Begin in Q1 of 2021.